RYWECK DANIEL E. enters SILO PHARMA, INC. with 4K shares — 100% direct ownership
Full direct ownership at entry is the strongest form of insider alignment with shareholders.
Direct
Filed: 10/4/2022ACC: 0001213900-22-062051
Officer· Chief Financial Officer
Since Sep 2022
4K
Baseline shares
100% direct
4K
Direct ownership
1 position
0.00
Derivative underlying
0 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned4K
Total
4K direct4K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 4K | Direct |
| Total | 4K | 4K direct |
Derivative Holdings0
No derivative holdings reported